Feb 6, 2018
The global Primary Biliary Cirrhosis Drug market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2018 and 2025.

Pune, India - February 6, 2018 /MarketersMedia/ —
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Primary Biliary Cirrhosis Drug in these regions, from 2013 to 2025 (forecast), covering
• North America
• Europe
• China
• Japan
• Southeast Asia
• India
Access Report Details at: https://www.themarketreports.com/report/global-primary-biliary-cirrhosis-drug-market-professional-survey-report-2018
Global Primary Biliary Cirrhosis Drug market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
• AlbireoPharma
• CymaBay Therapeutics, Inc.
• Dr. Falk Pharma GmbH
• Enanta Pharmaceuticals, Inc.
• GlaxoSmithKline Plc
• Intercept Pharmaceuticals, Inc.
• Johnson & Johnson
• MediGene AG
• NGM Biopharmaceuticals, Inc.
• Virobay Inc.
Purchase this Premium Report at: https://www.themarketreports.com/report/buy-now/910216
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
• Budesonide
• FFP-104
• GSK-2330672
• MBX-8025
• NGM-282
• Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Primary Biliary Cirrhosis Drug for each application, including
• Clinic
• Hospital
• Others
Inquire about this Report at: https://www.themarketreports.com/report/ask-your-query/910216
Contact Info:
Name: Shirish Gupta
Email: Send Email
Organization: The Market Reports
Address: SF-29, North Block, Sacred World, Wanawadi
Phone: +1-631-407-1315
For more information, please visit https://www.themarketreports.com/report/global-primary-biliary-cirrhosis-drug-market-professional-survey-report-2018
Source: MarketersMedia
Release ID: 297261
The once high-flying Danish drugmaker has struggled to fend off rivals in the weight-loss industry, especially Eli Lilly, which gave a much rosier outlook to investors.
New tools by artificial intelligence companies like Anthropic have reignited worries that businesses will pare down their subscriptions to software services.
The N.F.L. claims Guardian Caps reduce the risk of concussions. The company that makes them says, “It has nothing to do with concussions.”
Bar owner Jobe Ferguson says he is devastated to close TNQ in the Northern Quarter after 22 years.
The company reported total revenue of $802.3 million for the fourth quarter of 2025, up 10.4 percent from a year earlier.
Please tell us what changes you’ve made to your health and wellness practices to improve your brain function and job performance. We may include your experiences in an article.
Novo Nordisk is facing "unprecedented" price pressures, "intensifying competition" and patents expiring.
The two-year-old company, founded by veterans of the autonomous vehicle business Waymo, is seeking to automate excavators and other building equipment.
Precious metal price voliatility continues as geopolitical tensions push investors to safe-haven assets.
Prized for its beauty, teak is in short supply, forcing the yacht industry to look for alternatives.
Millions could be entitled to compensation as a result of commission arrangements between lenders and dealers.
In a country roiled by political upheaval recently, retiring the longtime currency, the lev, prompted some concern about inflation but little other angst.
When President Trump said he wanted to drive housing prices up, not down, he was speaking to a conundrum that has flummoxed policymakers for decades.
The legislation will impose new restrictions on pharmacy benefit managers, giant companies like CVS Caremark, Optum Rx and Express Scripts that oversee prescription drug benefits.
Gold has fallen from recent highs but there are several reasons investors are still finding refuge in the precious metal.
The social media platform recently announced that it was axing around 15% of its workforce.
Experts are reaching to divine the president’s approach to global policy and economics, with one theory seeing antecedents in centuries-old dynastic rule.
Tyson Foods said its beef business could lose up to $500 million this year as the supply of cattle reaches a 75-year low.
The show on Sunday drew about 14.4 million people. It is the second consecutive year that the awards ceremony attracted a smaller audience.
Elon Musk's X and Grok platforms are facing increased scrutiny from authorities on both sides of the channel.
Mr. Miran had taken a leave of absence from advising the president after adding a role at the Federal Reserve, drawing criticism from Democrats.
Senators asked Ted Sarandos about whether the acquisition would raise prices, squeeze talent and degrade the moviegoing experience.
Concerns were raised by a subcommittee including potential price rises and the future of cinemas.
Comac's passenger jet is attracting customers in South East Asia where demand for affordable aircraft is growing.
The company’s rapid e-commerce growth and push into automation and artificial intelligence propelled its stock into the trillion-dollar club.
Little snowpack, strikes by mountain staff and Trump administration policies that are keeping international visitors away have made this a difficult season in the Rockies and beyond.
The move followed a yearlong investigation into X and escalated a wider standoff between European officials and American tech companies over the regulation of social media.
A group of cryptocurrency investors backing a memecoin hopes the statue will soon be installed at one of Mr. Trump’s golf courses in Florida.
Officials and business leaders welcomed lower tariffs, but India has not yet confirmed that it would stop buying Russian oil, which President Trump said Prime Minister Narendra Modi had agreed to.
Newly released emails between Mr. Karp, the chairman of Paul Weiss, and Jeffrey Epstein reveal a number of social interactions between them.
The media giant chooses the head of its amusement park business to replace longtime boss Bob Iger.
Jeffrey Epstein wanted most of his money to go to his girlfriend. Mr. Epstein’s brother and a Harvard math professor were also named beneficiaries.
The food and beverage giant said consumers were facing “affordability limitations.”
But a lawyer who has been scrutinizing archives and UBS are in a dispute over access to about 150 documents.
The milestone reflects the US retail giant's booming e-commerce business and investors' embrace of its AI investments.
Novel approaches to the all-day cafe are working for diners and creative chefs across the country.
The snack conglomerate is cutting the price of products including Doritos, Cheetos and Lays
Mr. D’Amaro, 54, has most recently served as chairman of Disney Experiences, a division that includes theme parks, cruise vacations and consumer products.
Ms. Tanner was previously an executive at CBS News and serves on the board of Audacy, a major U.S. broadcaster and podcast producer.
Eluned Morgan said her government can't be expected "to step in and do the work" to save struggling pubs.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.